MAIA Biotechnology, Inc. Increase (Decrease) in Other Operating Assets
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-21
- MAIA Biotechnology, Inc. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was $0.00.
- MAIA Biotechnology, Inc. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- MAIA Biotechnology, Inc. increase (decrease) in other operating assets for the quarter ending 2022-06-30 was $0.00.
- MAIA Biotechnology, Inc. increase (decrease) in other operating assets for the quarter ending 2022-03-31 was -$322.00.
- MAIA Biotechnology, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$322.00, a 110.31% decline from fiscal 2021.
- MAIA Biotechnology, Inc. increase (decrease) in other operating assets for fiscal 2021 was $3.12K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | -$322.00 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | -$322.00 10-Q · filed 2023-11-07 | -$517.85K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$322.00 10-Q · filed 2023-08-08 | -$517.85K derived: sum of 3 quarters · filed 2023-08-08 | -$68.50K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$322.00 10-Q · filed 2023-05-08 | -$517.85K derived: sum of 2 quarters · filed 2023-05-08 | -$68.50K derived: sum of 3 quarters · filed 2023-05-08 | |
| 2021-12-31 | -$517.53K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-24 | -$68.17K derived: sum of 2 quarters · filed 2023-03-24 | $3.12K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $449.35K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-02-06 | $520.65K 10-Q/A · filed 2023-02-06 | ||
| 2021-06-30 | $71.30K 10-Q · filed 2022-08-22 |